Save time and get answers to complex questions with AI chat
Guselkumab patent expiration?When will latisse patent expire?When does guselkumab patent expire?How often should lurbinectedin's long term effects be monitored?Xiaflex market launch year?
See the DrugPatentWatch profile for Trelegy
Trelegy Ellipta contains three active ingredients per inhalation: - Fluticasone furoate 100 mcg - Umeclidinium bromide 55 mcg - Vilanterol trifenatate 25 mcg Inhalation is delivered via a dry-powder inhaler (Ellipta). The primary inactive ingredient is lactose monohydrate (used as a carrier for the powder). The exact excipient list can vary by country, so for the precise formulation you should check the patient information leaflet or local labeling. If you have a specific country or need more detail (e.g., allergy considerations), I can look up the exact label for that region.
Other Questions About Trelegy :